Program provides under-represented biotech entrepreneurs access to MBC BioLabs’ lab space, shared resources, and community to speed the creation of transformative life sciences startups
MBC BioLabs, with the support of AbbVie, announces the MBC BioLabs Diversity Golden Ticket, a program designed to support under-represented biotech entrepreneurs using innovative science to deliver solutions for human health. The award provides lab space fitted with state-of-the-art research equipment, professional support staff, conference room space for meetings with your team and potential investors, and a vibrant, collaborative community to share ideas and expertise with other exciting life science companies.
The Golden Ticket will be awarded to one early-stage company developing novel, transformational therapies.
Apply until November 18, 2022
The Under-represented Program is a new initiative of MBC BioLabs supported by AbbVie. The program seeks to enhance biotech innovation by providing fully equipped research facility access to diverse, qualified talent. Additionally, the program aims to facilitate broader access to the biotech industry for socioeconomically disadvantaged, underserved, and under-represented individuals and communities.
The ideal Diversity Golden Ticket candidate will meet the following criteria:
To apply, please upload your non-confidential company presentation by NOVEMBER 18, 2022.
In the presentation, please address:
Selected finalist will be invited to present at MBC Biolabs at an event to be held on December 5th, 2022. We look forward to receiving your application.
All the best of luck!